Post-Sling Urinary Retention in Women.
As many as 80 % of all women who complain of urine leakage will be diagnosed with stress urinary incontinence (SUI). As the population ages and SUI becomes more widespread, it is imperative to understand how to manage potential complications of the therapies used to treat this condition. As the mid-urethral sling has become the "gold standard" of SUI treatment, it is important to be aware of post-operative complications associated with this procedure. One significant complication of the MUS is subsequent urinary retention. In this review, we discuss the potential etiologies of post-sling urinary retention and outline the various modalities for achieving a timely and accurate diagnosis. We also emphasize the applications of various diagnostic tools, such as urodynamics, when evaluating patients with post-sling urinary retention. Lastly, various treatments for this complication are discussed. This chapter serves as a comprehensive overview of how to approach post-sling urinary retention, underlining the recent academic research contributions that have enhanced our understanding of how to manage this condition.
Departments of Urology and Obstetrics and Gynecology, Division of FPMRS, New York University Langone Medical Center, New York, NY, USA. dominique.malacarne@nyumc.org.
Dominique R
DR
Malacarne
Departments of Urology and Obstetrics and Gynecology, Division of FPMRS, New York University Langone Medical Center, New York, NY, USA.
Victor W
VW
Nitti
D005260:Female; D014943:Global Health; D006801:Humans; D015994:Incidence; D011183:Postoperative Complications / Q000453:epidemiology* / Q000209:etiology; D053825:Suburethral Slings / Q000009:adverse effects*; D014550:Urinary Incontinence, Stress / Q000601:surgery*; D016055:Urinary Retention / Q000453:epidemiology* / Q000209:etiology; D013520:Urologic Surgical Procedures / Q000009:adverse effects*
Mid-urethral sling; Stress urinary incontinence; Treatment; Voiding dysfunction
Urology. 2005 Sep;66(3):523-6
16140070
Neurourol Urodyn. 2016 Nov;35(8):939-943
26207847
BJOG. 2007 May;114(5):522-31
17362484
Int Urogynecol J. 2010 Feb;21(2):229-33
19834633
Female Pelvic Med Reconstr Surg. 2013 Jul-Aug;19(4):191-8
23797515
Female Pelvic Med Reconstr Surg. 2013 Jan-Feb;19(1):46-50
23321659
J Urol. 2014 Mar;191(3):710-4
24060639
JAMA Surg. 2015 Dec;150(12):1167-75
26352538
Obstet Gynecol. 2012 Mar;119(3):539-46
22353951
Nat Rev Urol. 2012 Aug;9(8):429-34
22664930
J Urol. 2004 Oct;172(4 Pt 1):1379-81
15371849
J Urol. 2013 Aug;190(2):598-602
23567748
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul;20(7):855-8
19495549
J Urol. 2003 Mar;169(3):1013-6
12576834
N Engl J Med. 2007 May 24;356(21):2143-55
17517855
J Urol. 1997 Sep;158(3 Pt 1):875-80
9258103
Int Urogynecol J. 2013 Feb;24(2):331-6
22752015
World J Urol. 2015 Sep;33(9):1243-50
26025190
Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jan-Feb;15(1):25-31; discussion 31
14752595
J Urol. 2008 Nov;180(5):1890-7
18801499
Urology. 2001 Nov;58(5):697-701
11711343
N Engl J Med. 2010 Jun 3;362(22):2066-76
20479459
Ann R Coll Surg Engl. 2012 Oct;94(7):517-22
23031773
Neurourol Urodyn. 2014 Sep;33(7):1147-51
23818418
Neurourol Urodyn. 2015 Nov;34(8):736-40
25212178
Neurourol Urodyn. 2017 Mar;36(3):722-726
27037856
Female Pelvic Med Reconstr Surg. 2014 May-Jun;20(3):123-5
24763151
J Urol. 1999 May;161(5):1535-40
10210391
Am J Obstet Gynecol. 2011 Nov;205(5):498.e1-6
21925636
Int Urogynecol J. 2013 Jun;24(6):999-1004
23093323
Am J Obstet Gynecol. 2013 Jan;208(1):73.e1-7
23099189
Urology. 2002 Jan;59(1):47-51; discussion 51-2
11796279
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD006375
19821363
Nat Rev Urol. 2015 Sep;12(9):481-509
26282209
BJU Int. 2011 Nov;108 Suppl 2:24-8
22085122
Obstet Gynecol. 2003 May;101(5 Pt 1):929-32
12738152
J Urol. 2010 May;183(5):1906-14
20303102
Int Urogynecol J. 2013 Dec;24(12):2145-6
24154742
Curr Opin Urol. 2015 Jul;25(4):292-5
26049870